All sponsors

Cytokinetics $CYTK

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-34
RECRUITING2
READOUTS ≤12 MONTHS1
READOUT SLIPPED >6 MO40%

Delay Index: of 5 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +3.0 months). See all sponsors →

Open Cytokinetics on the live radar map → 📅 $CYTK readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ACACIA-HCM
NCT06081894
P3Active, not recruitingSymptomatic Non-Obstructive Hypertrophic Cardiomyopathy5002026-08-31 (+3 mo)
AMBER-HFpEF
NCT06793371
P2RecruitingSymptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)602026-09
COMET-HF
NCT06736574
P3RecruitingHeart Failure; Heart Failure With Reduced Ejection Fraction18002027-09
FOREST-HCM
NCT04848506
P2/3Enrolling by invitationSymptomatic Hypertrophic Cardiomyopathy (HCM)9002029-03 (+36 mo)
CEDAR-HCM
NCT06412666
P2/3Active, not recruitingPediatric; Symptomatic Obstructive Hypertrophic Cardiomyopathy652030-01 (+13 mo)